
Sign up to save your podcasts
Or


In this interview, Erik Magnus Ohman and Jane Margaret Armitage discuss ASCEND, a randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes.
By American College of Cardiology3.8
5454 ratings
In this interview, Erik Magnus Ohman and Jane Margaret Armitage discuss ASCEND, a randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes.

139 Listeners

318 Listeners

499 Listeners

169 Listeners

884 Listeners

291 Listeners

140 Listeners

1,156 Listeners

40 Listeners

196 Listeners

90 Listeners

363 Listeners

427 Listeners

372 Listeners

32 Listeners